Previous Article | Next Article 
Infection and Immunity, February 2000, p. 658-663, Vol. 68, No. 2
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Occurrence of Severe Destructive Lyme Arthritis in
Hamsters Vaccinated with Outer Surface Protein A and Challenged
with Borrelia burgdorferi
Cindy L.
Croke,1,2
Erik L.
Munson,1,2
Steven D.
Lovrich,3
John A.
Christopherson,1,2
Monica C.
Remington,1,2
Douglas M.
England,4,5
Steven M.
Callister,3,6 and
Ronald F.
Schell1,2,7,*
Wisconsin State Laboratory of
Hygiene1 and Departments of Medical
Microbiology and Immunology,2
Bacteriology,7 and Pathology and
Laboratory Medicine,4 University of Wisconsin,
Madison, Wisconsin 53706; Department of Pathology, Meriter
Hospital, Madison, Wisconsin 537155; and
Microbiology Research Laboratory3 and
Section of Infectious Diseases,6
Gundersen Lutheran Medical Center, La Crosse, Wisconsin 54601
Received 31 August 1999/Returned for modification 27 October
1999/Accepted 10 November 1999
Arthritis is a frequent and major complication of infection with
Borrelia burgdorferi sensu stricto. The antigens
responsible for the induction of arthritis are unknown. Here we provide
direct evidence that a major surface protein, outer surface protein A (OspA), can induce arthritis. Hamsters were vaccinated with 30, 60, or
120 µg of recombinant OspA (rOspA) in aluminum hydroxide and
challenged with B. burgdorferi sensu stricto isolate 297 or C-1-11. Swelling of the hind paws was detected in 100, 100, and 50% of
hamsters vaccinated with 30, 60, or 120 µg of rOspA, respectively. In
addition, arthritis developed in 57% of hamsters vaccinated with a
canine rOspA vaccine after infection with B. burgdorferi sensu stricto. When the canine rOspA vaccine was combined with aluminum
hydroxide, all vaccinated hamsters developed arthritis after challenge
with B. burgdorferi sensu stricto. Histopathologic examination confirmed the development of severe destructive arthritis in rOspA-vaccinated hamsters challenged with B. burgdorferi
sensu stricto. These findings suggest that rOspA vaccines should be modified to eliminate epitopes of OspA responsible for the induction of
arthritis. Our results are important because an rOspA vaccine in
aluminum hydroxide was approved by the Food and Drug Administration for
use in humans.
*
Corresponding author. Mailing address: Wisconsin State
Laboratory of Hygiene, University of Wisconsin, 465 Henry Mall,
Madison, WI 53706. Phone: (608) 262-3634. Fax: (608) 265-3451. E-mail: rfschell{at}facstaff.wisc.edu.
Infection and Immunity, February 2000, p. 658-663, Vol. 68, No. 2
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Kotloski, N. J., Nardelli, D. T., Peterson, S. H., Torrealba, J. R., Warner, T. F., Callister, S. M., Schell, R. F.
(2008). Interleukin-23 Is Required for Development of Arthritis in Mice Vaccinated and Challenged with Borrelia Species. CVI
15: 1199-1207
[Abstract]
[Full Text]
-
Nardelli, D. T., Callister, S. M., Schell, R. F.
(2008). Lyme Arthritis: Current Concepts and a Change in Paradigm. CVI
15: 21-34
[Full Text]
-
Peterson, S. H., Nardelli, D. T., Warner, T. F., Callister, S. M., Torrealba, J. R., Schell, R. F.
(2007). Anti-p19 Antibody Treatment Exacerbates Lyme Arthritis and Enhances Borreliacidal Activity. CVI
14: 510-517
[Abstract]
[Full Text]
-
Nardelli, D. T., Warner, T. F., Callister, S. M., Schell, R. F.
(2006). Anti-CD25 Antibody Treatment of Mice Vaccinated and Challenged with Borrelia spp. Does Not Exacerbate Arthritis but Inhibits Borreliacidal Antibody Production.. CVI
13: 884-891
[Abstract]
[Full Text]
-
Amlong, C. A., Nardelli, D. T., Peterson, S. H., Warner, T. F., Callister, S. M., Schell, R. F.
(2006). Anti-Interleukin-15 Prevents Arthritis in Borrelia-Vaccinated and -Infected Mice. CVI
13: 289-296
[Abstract]
[Full Text]
-
Nardelli, D. T., Burchill, M. A., England, D. M., Torrealba, J., Callister, S. M., Schell, R. F.
(2004). Association of CD4+ CD25+ T Cells with Prevention of Severe Destructive Arthritis in Borrelia burgdorferi-Vaccinated and Challenged Gamma Interferon-Deficient Mice Treated with Anti-Interleukin-17 Antibody. CVI
11: 1075-1084
[Abstract]
[Full Text]
-
Munson, E. L., DeCoster, D. J., Nardelli, D. T., England, D. M., Callister, S. M., Schell, R. F.
(2004). Neutralization of Gamma Interferon Augments Borreliacidal Antibody Production and Severe Destructive Lyme Arthritis in C3H/HeJ Mice. CVI
11: 35-41
[Abstract]
[Full Text]
-
Burchill, M. A., Nardelli, D. T., England, D. M., DeCoster, D. J., Christopherson, J. A., Callister, S. M., Schell, R. F.
(2003). Inhibition of Interleukin-17 Prevents the Development of Arthritis in Vaccinated Mice Challenged with Borrelia burgdorferi. Infect. Immun.
71: 3437-3442
[Abstract]
[Full Text]
-
Christopherson, J. A., Munson, E. L., England, D. M., Croke, C. L., Remington, M. C., Molitor, M. L., DeCoster, D. J., Callister, S. M., Schell, R. F.
(2003). Destructive Arthritis in Vaccinated Interferon Gamma-Deficient Mice Challenged with Borrelia burgdorferi: Modulation by Tumor Necrosis Factor Alpha. CVI
10: 44-52
[Abstract]
[Full Text]
-
Munson, E. L., Du Chateau, B. K., Jensen, J. R., Callister, S. M., DeCoster, D. J., Schell, R. F.
(2002). Gamma Interferon Inhibits Production of Anti-OspA Borreliacidal Antibody In Vitro. CVI
9: 1095-1101
[Abstract]
[Full Text]
-
Parenti, D. L., Schell, R. F., Callister, S. M., Lovrich, S. D.
(2000). Outer Surface Protein A and Arthritis in Hamsters. Infect. Immun.
68: 7212-7213
[Full Text]
-
Munson, E. L., Du Chateau, B. K., Jobe, D. A., Lovrich, S. D., Callister, S. M., Schell, R. F.
(2000). Production of Borreliacidal Antibody to Outer Surface Protein A In Vitro and Modulation by Interleukin-4. Infect. Immun.
68: 5496-5501
[Abstract]
[Full Text]